Penny Daugherty on Discussing Patients' Genetics

Name: Penny Daugherty on Discussing Patients' Genetics
Uploaded: 2013-09-11T10:46:39.000Z
Description: Penny Daugherty, RN, MS, OCN, Southeastern Gynecologic Oncology, explains how nurses in her practice discuss genetics and genomics with patients.

September 11, 2013

Penny Daugherty

Article

Penny Daugherty, RN, MS, OCN, Southeastern Gynecologic Oncology, explains how nurses in her practice discuss genetics and genomics with patients.

Daugherty says that information on genetics counseling is distributed to patients. If the patient wishes to discuss the contents of the packet, the nurses make themselves available.

Genetics counselors are also present at support group meetings to answer any questions that patients may have, Daugherty says. Genetics presenters will educate nurses on genetics and genomics so that nurses can provide better care to patients.

Related Content

dna genetics genomic tests © marina zlochin -adobe.stock.com.png

Out-of-Pocket Costs, Insurance Status May Impact Genomic Testing Rates

April 10th 2024

Article

Genetic testing decisions in patients with cancer may be affected by significant out-of-pocket costs.

Should You Wait for NGS Results Before Initiating NSCLC Treatment?

November 17th 2023

Article

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

Are At-Home Genomic Tests Such as 23andMe Ethical?

September 22nd 2023

Article

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, explains the pitfalls with at-home genomic tests and why nurses must be ready to talk to their patients about genetic counseling.

Increase in Direct-to-Consumer Genomic Testing Yields New Ethical Considerations for Oncology Nurses

August 10th 2023

Article

Oncology nurses make the case for nurse intervention with direct-to-consumer genomic testing.

Oncology Nurses Play a Vital Role in Fostering Biomarker Testing Conversations With Patients

April 28th 2023

Article

Julie C. Martin DNP, AOCN, FNP-BC, discusses best practices to approaching conversations on clinically actionable genomic results with patients.

CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines

April 18th 2023

Article

Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines.

Related Content

Out-of-Pocket Costs, Insurance Status May Impact Genomic Testing Rates

April 10th 2024

Article

Genetic testing decisions in patients with cancer may be affected by significant out-of-pocket costs.

Should You Wait for NGS Results Before Initiating NSCLC Treatment?

November 17th 2023

Article

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

Are At-Home Genomic Tests Such as 23andMe Ethical?

September 22nd 2023

Article

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, explains the pitfalls with at-home genomic tests and why nurses must be ready to talk to their patients about genetic counseling.

Increase in Direct-to-Consumer Genomic Testing Yields New Ethical Considerations for Oncology Nurses

August 10th 2023

Article

Oncology nurses make the case for nurse intervention with direct-to-consumer genomic testing.